학술논문
LBA54 Alkylating agent-based vs oxaliplatin-based chemotherapy in neuroendocrine tumours according to the O6-methylguanine-DNA methyltransferase (MGMT) status: A randomized phase II study (MGMT-NET) on behalf of the French Group of Endocrine Tumors (GTE) and ENDOCAN-RENATEN network
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S1292-S1293
Subject
Language
ISSN
0923-7534